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Abstract
This study quantified the effect of age on cerebrovascular reactivity and cerebrovascular conductance while accounting
for differences in grey matter volume in younger (YA: n ¼ 12; 24  4 years, six females) and older adults (OA: n ¼ 10;
66  7 years; five females). Cerebral blood flow velocity (CBFV; transcranial Doppler) in the middle cerebral artery
(MCA), MCA cross-sectional area (CSA), intracranial volumes (magnetic resonance imaging), and mean arterial pressure
(MAP; Finometer), were measured under normocapnic and hypercapnic (6% carbon dioxide) conditions. Cerebral blood
flow (CBF) was quantified from CBFV and MCA CSA and normalized to grey matter volume. Grey matter volume was
719  98 mL in YA and 622  50 mL in OA (P ¼ 0.009). Cerebrovascular reactivity (%CBF/PETCO2) was not different
between YA and OA. In contrast, cerebrovascular conductance (CBF/MAP) in response to hypercapnia was reduced in
OA (P ¼ 0.02). Of note, MAP increased more with hypercapnia in OA compared with YA. Therefore, the central
hemodynamic response to hypercapnia compensated for a diminished dilatory response downstream from the MCA
so that the CBF response to hypercapnia per unit of brain mass was not affected by age. This impairment was not
detected by traditional measures of cerebrovascular reactivity.
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Introduction
Age remains a major risk factor for development of
cerebrovascular disease1 and reduced reactivity to vasodilators represents an early sign of abnormal cerebrovascular health. In the case of the cerebral circulation,
indicators of the relative change in cerebral blood ﬂow
velocity (CBFV), or cerebral blood ﬂow (CBF), per unit
change in the partial pressure of carbon dioxide are
used commonly to assess an index of cerebrovascular
reactivity (CVR). In general, a small CVR is interpreted
as increased risk of stroke and all-cause mortality.2,3
Aging reduces absolute CBFV, as measured at the
middle cerebral artery (MCA) with transcranial
Doppler ultrasound.4–6 However, the evidence regarding the eﬀect of age on CVR remains unclear with some
studies reporting a decreased CVR,4,7–9 while others
reported no diﬀerence.6,10–12 Diﬀerent vasodilatory stimuli, ranging from 5 to 7% CO2 in room air4,6–12 or
5% CO2 in 95% oxygen,7 or measures of CBFV versus
CBF (transcranial Doppler ultrasound,4,6–8,10,11 positron emission tomography,12 xenon inhalation9) represent potential sources of variation amongst studies.

To relate measures of CBFV, as made by transcranial Doppler ultrasound in the MCA, for example, to
CBF, additional details are needed regarding the baseline diameter of this vessel, as well as the vasoreactivity
of subcortical vessels through which blood ﬂow velocity
data are obtained. Other sources of variation include
contributions of central hemodynamics to brain perfusion and the brain volume being perfused. These values
are diﬃcult to obtain and many studies obtain CVR
data using transcranial Doppler methods that target
the MCA with the assumption that the cross-sectional
area of the MCA does not change. However, recent
measures using 3T13,14 and 7T15 magnetic resonance
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imaging (MRI) in separate groups of young healthy
subjects indicate that the cross-sectional area of the
MCA increases by approximately 8% during hypercapnia with 6% CO2. Thus, CVR as calculated using CBF
was 58% greater than CVR calculated from CBFV.14
Clearly, at least in young adults, the vasoreactivity of
the MCA makes considerable contributions to the overall cerebrovascular dilatory response to hypercapnia.
To date, however, the impact of healthy aging on
MCA vasoreactivity has not been reported. These features are important because CVR reﬂects the relative
change in ﬂow for a given stimulus, such as carbon
dioxide, but does not quantify speciﬁcally the dilatory
response. Rather, an increase in CBF during hypercapnia could be a result of vasodilation and/or changes in
perfusion pressure, the proportions of which may
change with age. Failure to account for these possibilities may lead to erroneous conclusions about vasoreactivity. Thus, we argue that evaluations of changes in
cerebrovascular conductance are required to interpret
cerebral vasoactive properties and responses.
Additionally, brain atrophy occurs with aging and is
more pronounced in grey matter than white matter.16
This atrophy may occur to a greater extent in the frontal and parietal portions of the cerebral cortex, including those perfused by the MCA vascular bed.17,18
Normalization of CBF to changes in cortical volume
is expected to more accurately establish age-related
changes in brain blood ﬂow.
The purpose of this study was to test the overall
hypothesis that advancing age impairs cerebrovascular
dilation. These studies incorporated evaluations of
brain volume, MCA dilation to hypercapnia, and central hemodynamics, in cohorts of young adults (YA)
and older adults (OA).

Materials and methods
Ten older subjects aged 59 to 75 years (66  7 years, ﬁve
females) and 12 younger subjects (24  4 years, range
20–30 years, six females) gave informed consent to participate in this study that was approved by the Health
Sciences Research Ethics Board at Western University
and performed in accordance with the Declaration of
Helsinki. Subjects were non-smokers who had no history of cardiovascular disease. Two of the participants
were medicated at the time of the study: one female OA
was taking 10 mg per day of Clobazam for seizures (but
had not had a seizure in 13 years), and one older male
was taking Warfarin for a blood clot that occurred ﬁve
years prior. All participants were recreationally active.
Female OA reported that they were postmenopausal
(conﬁrmed by sex hormone analysis) and not on hormone replacement therapy. Young female participants
were studied in the early follicular phase of their
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menstrual cycle (days 1–6) or the low hormone phase
of oral contraceptives (four of six young female participants were taking oral contraceptives).

Experimental protocols and measurements
All participants participated in a familiarization session
and two experimental sessions, including what will be
referred to as an MRI day and a Laboratory day.
During the familiarization session, all experimental
protocols were thoroughly explained, participants practiced breathing 6% CO2, and completed the Montreal
Cognitive Assessment (MoCA: www.mocatest.org)19
and the Trail Making Test to assess cognitive abilities.20
Prior to each experimental session, participants were
asked to refrain from alcohol, physical activity, and
caﬀeine, for 12 h. During the Laboratory session, a
blood sample was obtained after a 12-h fast that was
analyzed for blood glucose, hemoglobin, cholesterol,
triglycerides, 17-b estradiol, progesterone, and testosterone concentrations. A small meal consisting of a
granola bar and juice was then provided. For the
MRI day, participants ate a small breakfast 3 h prior
to the testing session.
For each day, a hypercapnia trial was performed
where participants breathed a gas mixture containing
6% CO2, 21% oxygen, balance nitrogen. Each of these
hypercapnia trials consisted of approximately 3 min of
baseline and 5 min of hypercapnia. During hypercapnia, the partial pressure of oxygen was not clamped
because the ensuing hyperventilation would, if anything, augment alveolar PO2, minimizing any risk of
additional hypoxia.

Laboratory session
Initially, three seated blood pressure measurements
were made (HEM-790-ITCAN, Omron, Lake Forest,
IL, USA). To gain insight into the general vascular
health of each individual, images of the right and left
common carotid artery (10 MHz probe; Vivid 7 system,
GE HealthCare Canada, Mississauga, ON, Canada)
were captured while supine in order to quantify
intima-media thickness (IMT). To assess brachial endothelial function, a ﬂow-mediated dilation protocol was
performed where ischemia was induced for 5 min using
an air bladder cuﬀ positioned around the forearm and
inﬂated to supra-systolic levels. Longitudinal images of
vessel diameter were made at baseline (average of three
measures) and every 15 s for 3 min after release of forearm ischemia. Throughout all protocols, the heart rate
was acquired from a standard ECG recording. Arterial
blood pressure was measured using ﬁnger cuﬀ plethysmography (Finometer, Finapres Medical Systems BV,
Amsterdam, The Netherlands) and the brachial blood
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pressure derived from the ﬁnger pressure waveform was
corrected to manual sphygmomanometric values.
Respiration rate and PETCO2 were monitored with a
strain gauge and a gas analyzer (ML206,
ADInstruments, Colorado Springs, CO, USA), respectively. In the supine position, the right MCA was insonated to measure CBFV (2 MHz pulsed wave TCD
probe; Neurovision, Multigon Industries, Elmsford,
CA, USA) with an average insonation depth of
4.9  0.4 cm in YA and 5.0  0.5 cm in OA.

MRI session
CBFV and MCA CSA were collected at the same time of
day on separate days and, on average, the interval
between each test was 11  11 days. Magnetic resonance
imaging was performed with a 3T system (Magnetom
Prisma, Siemens Medical Solutions, Erlangen,
Germany). A 3D time-of-ﬂight pulse sequence exposed
the location on the M1 segment of the MCA for application of a T2 fast spin echo sequence (eight slices, repetition time ¼ 3000 ms, echo time ¼ 96 ms, ﬂip
angle ¼ 120 , voxel dimensions ¼ 0.4  0.4  2.0 mm3).
The T2 sequence was gated to the peak of the pulse
wave measured at the third ﬁnger of the right
hand with an MRI-compatible pulse oximeter (8600FO
MRI, Nonin Medical Inc., Plymouth, MN, USA).
Collection of an image took approximately 1.25 min.
Respiration was monitored with a strain gauge around
the upper abdomen and PETCO2 data were collected as
described during the Lab session.
Additionally, a T1-weighted structural image was
acquired with a 3D MP-RAGE pulse sequence for
determination of grey matter, white matter, and cerebrospinal ﬂuid volume (repetition time ¼ 2.3 ms,
echo time ¼ 30 ms, ﬂip angle ¼ 9 , voxel dimensions ¼
1.0  1.0  1.0 mm).

Data analysis
The right and left common carotid artery IMT was
quantiﬁed with calipers (GE Echopac software) at
end-diastole at three regions along the artery and averaged. An independent observer also completed the analysis and the intra-class coeﬃcient between the
observers was 0.99 (P < 0.001); therefore, an average
of the values from the two investigators is reported.
To assess brachial endothelial function, the peak diastolic diameter during the reactive phase (normally
occurring at 60–90 s)21 was used for statistical analysis.
Two observers also completed brachial measurements
and the intra-class correlation coeﬃcient was 0.99
(P < 0.001).
Baseline PETCO2 values from the MRI were corrected to Lab values. This was done because the
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length of the hose to the CO2 analyzer (located outside the MRI area) resulted in a systematic and constant
damping of the signal that diminished PETCO2 values at
baseline. Since there was no diﬀerence in respiration
rates between the Lab and MRI day, we corrected
MRI values to the average baseline Lab PETCO2. The
MCA CSA was measured manually by two blinded
observers using Osirix imaging software (Pixmeo,
Bernex, Switzerland) and the data from both observers
were averaged and reported. The agreement between the
two observers was very good (intra-class correlation
coeﬃcient was 0.99 (P < 0.001)). The reported
CSA during hypercapnia is the maximal value from
the 5-min period and this is reported along with absolute and percent change (%) from baseline. All other
reported variables for hypercapnia correspond to this
maximal CSA value. Cerebral blood ﬂow was calculated
as CBF (ml/min) ¼ CBFV (cm/s)  CSA (cm2)  60 (s/
min). CBFV and CBF are also reported as %.
Using SPM 8 (http://www.ﬁl.ion.ucl.ac.uk/spm/),
high-dimensional spatial normalization was performed
with T1 images using the DARTEL toolbox. Images
were then segmented into grey matter, white matter,
and cerebrospinal ﬂuid. Total intracranial volume was
calculated as the sum of these three components.
Cerebrovascular conductance was calculated as the
quotient of CBF and MAP, along with absolute and
percent change. CVR indices were calculated both as
the percent and absolute change in CBF and CBFV per
mmHg change in PETCO2 at approximately every
1.25 min during hypercapnia (to correspond with the
timing of MCA images).

Statistical analysis
The eﬀects of group (YA versus OA) and condition
(baseline versus hypercapnia) were assessed using a
general linear mixed model ANOVA and a HolmSidak post-hoc test for pairwise comparisons
(SigmaStat 12.0; Systat Software, San Jose, CA).
Unpaired t-tests were used to assess the impact of
group on grey matter, white matter, and cerebrospinal
ﬂuid as well as on relative (%) indices. Regression
analysis quantiﬁed the relationship between grey
matter volume and CBF. An ANCOVA compared
the slope of the regression lines for YA and OA
(SPSS 20.0; IBM Corporation, Armonk, NY). In addition, we performed ANCOVA analysis to determine
the eﬀect of age on CBF when controlling for grey
matter (GM) volume. Since GM had a signiﬁcant
eﬀect on CBF, in this model we normalized all measurements of CBFV, CBF, CVC, and CVR to grey
matter volume and these variables are reported as
CBFVGM, CBFGM, CVCGM, and CVRGM. The probability level for statistical signiﬁcance was p  0.05.
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Results
Baseline measures
Testosterone levels in older postmenopausal women
(0.9  0.4 nmol/L) were greater than YA females
(0.5  0.2 nmol/L; P ¼ 0.03) and 17-b estradiol levels
were not detectable in four of ﬁve OA females. In the
female with detectable estradiol, the levels were within
the postmenopausal range (<202 pmol/L). On average,
OA had greater seated systolic blood pressure, fasting
glucose, total and LDL cholesterol, triglycerides and
hemoglobin A1C levels than YA; however, these
values were within the normal range (Table 1). On the
separate testing days (Lab and MRI), the pre-test
seated blood pressure was not diﬀerent in either YA
or OA. Older adults had greater IMT of the left and
right common carotid arteries (Table 1). The FMD
response was approximately 50% less in OA compared
to YA (P ¼ 0.04; Table 1). There were no diﬀerences in
MoCA scores or Trail Making Test between groups
(Table 1). Grey matter volume was less in OA compared to YA (YA: 719  98 ml; OA: 622  50 ml;
P ¼ 0.008) while white matter volume was not diﬀerent
(YA: 536  60 ml; OA: 545  58 ml). Compared to YA,
cerebrospinal ﬂuid volume was greater in OA (YA:
222  37 ml; OA: 266  40 ml P ¼ 0.02), but the total

intracranial volume was not diﬀerent between groups
(YA: 1476  175 ml; OA: 1432  131 ml). The Pearson’s
correlation between baseline CBF and grey matter was
r ¼ 0.76 (P ¼ 0.004) in YA and r ¼ 0.57 (P ¼ 0.08) in
OA (Figure 1). Of note, the slopes of these relationships
were similar between groups, but a marked reduction in
grey matter volume in the OA group restricted the
range of comparison. In addition, ANCOVA analysis
indicated a signiﬁcant impact of gray matter volume in
the model of how age predicted CBF (P ¼ 0.003) and
there was no eﬀect of age on CBF after controlling for
grey matter volume.

Cerebrovascular reactivity measures
Table 2 illustrates the respiratory and blood pressure
responses to hypercapnia. Of these, pertinent observations were the main eﬀects of condition (P ¼ 0.003) and
group (P ¼ 0.002) for respiration during the MRI test
with values being greater in YA compared to OA
(Table 2). Also, MAP was greater in OA than YA
at baseline (P ¼ 0.01) and during hypercapnia
(P < 0.001; Table 2). Importantly, compared to YA,
the increase in MAP on going from baseline to
the point of peak CSA in hypercapnia was greater in
OA (YA: 2.7  2.9 mmHg; OA: 6.8  4.5 mmHg;
P ¼ 0.03).

Table 1. Subject characteristics.

n, Male/female
Height (cm)
Weight (kg)
BMI (kg/m2)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Glucose (mmol/L)
Total cholesterol (mmol/L)
HDL cholesterol (mmol/L)
LDL cholesterol (mmol/L)
Triglycerides (mmol/L)
HbA1C (%)
IMT (mm)
FMD (%)
MoCA score (out of 30)
Trail Making Test (s)

Right
Left

Part A
Part B

YA

OA

12, 6/6
173  14
69  14
23  3
112  9
72  6
4.8  0.5
3.92  0.50
1.50  0.46
2.10  0.47
0.70  0.27
5.3  0.2
0.44  0.05
0.48  0.06
8.4  4.5
28  1
19  6
41  13

10, 5/5
171  12
74  14
25  3
123  11*
75  11
5.4  0.4*
5.00  0.77*
1.59  0.45
2.94  0.51*
1.05  0.48*
5.7  0.3*
0.73  0.13*
0.74  0.17*
4.7  1.5*
28  2
26  10
61  33

Values are mean  standard deviation. BMI, body mass index; BP, blood pressure; FMD, brachial artery flow-mediated dilation; HbA1C,
hemoglobin A1C; HDL, high density lipoprotein; IMT, intima-media thickness; LDL, low density lipoprotein; MoCA, Montreal cognitive
assessment; OA, older adults; YA, young adults. *P < 0.05 versus YA.
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Figure 1. The relationship between baseline cerebral blood flow (CBF) and grey matter volume (GM) in young adults (YA) and older
adults (OA). For YA, the equation of the regression line is CBF ¼ 89.21 þ 0.49  GM and for OA CBF ¼ 176.67 þ 0.64  GM.

Table 2. Physiological characteristics at baseline and hypercapnia (HC) for Laboratory and MRI days.
YA

LAB
Heart rate (bpm)
MAP (mmHg)
SBP (mmHg)
DBP (mmHg)
Respiration (breaths per minute)
PETCO2 (mmHg)
MRI
Heart rate (bpm)
Respiration (breaths per minute)
PETCO2 (mmHg)

OA

P-value

Baseline

HC

Baseline

HC

Condition

Group

Interaction

65  9
84  6
114  10
68  7
13  3
38  4

71  10
87  9*
116  12
71  7
14  5
49  4

62  11
93  8y
124  10*
73  10
11  3
39  3

68  11
100  7*y
132  10*y
77  10
11  3
49  4

<0.001
<0.001
<0.001
<0.001
0.62
<0.001

0.49
0.002
0.07
0.13
0.07
0.97

0.97
0.02
0.04
0.29
0.93
0.95

71  13
15  3
38  4

78  13
17  4
51  2

69  15
10  4
38  3

74  15
11  4
51  3

<0.001
0.003
<0.001

0.57
0.002
0.67

0.42
0.83
0.80

Values are mean  standard deviation. DBP, diastolic blood pressure; HC, hypercapnia; MAP, mean arterial pressure; OA, older adults; PETCO2, partial
pressure of end tidal carbon dioxide; SBP, systolic blood pressure; YA, young adults. *P < 0.05 compared to baseline. yP < 0.05 compared to YA.

Individual patterns of change in MCA CSA are
shown for YA and OA in Figure 2(a) and (b), respectively. Speciﬁcally, in YA, MCA CSA increased from
6.5  1.6 to 7.1  1.4 mm2 with hypercapnia with all
participants demonstrating a similar increase. In contrast, MCA CSA changed from 7.0  1.2 to

7.3  1.4 mm2 in OA with a less consistent eﬀect
across participants. Compared to baseline, absolute
MCA CSA increased with hypercapnia (main eﬀect of
condition P < 0.001) (Figure 2(c)). Overall, the diﬀerence in CSA (Figure 2(d)) on going from baseline to
hypercapnia was not diﬀerent between groups
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Figure 2. Middle cerebral artery cross-sectional area (CSA) during hypercapnia in young adults (YA; a) and older adults (OA; b)
expressed as absolute values (c), absolute change (d) and percent change CSA (e). *P < 0.05 versus YA.

(P ¼ 0.11) while the %CSA was greater in YA compared to OA (P ¼ 0.04; Figure 2(e)) but the slightly
larger baseline MCA in the OA group likely inﬂuenced
this latter comparison.
In both groups, CBFVGM (Figure 3(a)) and CBFGM
(Figure 3(b)) increased with hypercapnia (main eﬀect of
condition: P < 0.001), but no eﬀect of group was
observed. However, the %CBFVGM was less than
%CBFGM in both groups (YA: P < 0.001; OA:
P ¼ 0.04; Figure 3(c)) indicating an important inﬂuence
of MCA cross-sectional area on the cerebrovascular
response to hypercapnia.
Baseline CVCGM was not diﬀerent between YA and
OA (Figure 4(a)). Although CVCGM increased in both
groups in response to hypercapnia (P < 0.001;
Figure 4(a)), the end levels of conductance were less
in OA (0.0052  0.002 ml/min/mmHg) than YA
(0.0064  0.001 ml/min/mmHg) (P ¼ 0.02; Figure 3(a);
eﬀect size ¼ 0.64, 1  b ¼ 0.4). The increase in CVCGM
was 2.1  103  0.78  103 ml/min/mmHg in YA
compared to 1.4  103  0.68  103 ml/min/mmHg
in OA (P ¼ 0.05; Figure 4(b); eﬀect size ¼ 0.95;
1  b ¼ 0.69). Additionally, the % CVC was
50  23% in YA and 37  16% in OA (P ¼ 0.16;
Figure 4(c); eﬀect size ¼ 0.96; 1  b ¼ 0.57).
CVR was studied in absolute and relative terms using
both CBFVGM and CBFGM to account for the eﬀect of

MCA CSA changes on CVR estimates. There was no
eﬀect of group (YA versus OA; Figure 5) for absolute
CVR, but CBFVGM underestimated the response in
comparison to CBFGM in YA when considered in relative terms (P < 0.001; Figure 5(b)). Therefore, in YA
only, failure to account for MCA changes resulted in
decreased relative CVRGM estimates. Additionally,
there was a main eﬀect of CBFVGM versus CBFGM
for absolute CVR (Figure 5(a)).
The proportionate errors created in the CVRGM estimate by not accounting for MCA dilation and subsequent use of CBFGM versus CBFVGM, are illustrated
for each individual, as well as the group averages, in
Figure 5(c). These data illustrate that the errors are
greater in YA (40  38%) compared to OA
(3  24%; P ¼ 0.01; eﬀect size ¼ 1.16, 1  b ¼ 0.71).

Discussion
The main ﬁndings of this study are as follows: (1) agerelated cerebral atrophy aﬀected values of baseline
mean ﬂow velocity and CBF between YA and OA.
(2) The increase in MCA cross-sectional area with
hypercapnia was similar between groups. (3) The
CVRGM response to hypercapnia was similar between
the two groups due to a compensatory mean arterial
pressure response in the OA group. (3) The global
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Figure 3. Cerebral blood flow velocity (CBFVGM; a) and cerebral blood flow (CBFGM; b) at baseline and during hypercapnia in young
adults (YA) and older adults (OA) expressed as absolute values and percent change (c). *P < 0.05 versus CBFVGM.

dilation response, as quantiﬁed by CVCGM, was diminished in the OA group for the same PETCO2 stimulus.
(4) Despite the diminished dilation in OA, a compensatory MAP response resulted in a ‘‘normal’’ total
CBFGM. Therefore, an error resulted in interpreting
CVRGM as a dilation signal.
Several conclusions are drawn from these observations. First, MCA dilation was observed during the
hypercapnia challenge used here in all YA and in all
but two OA participants. However, age did produce a
more consistent impairment of vascular reactivity to
hypercapnia in the vascular bed downstream from the
MCA, as indicated by the CVC data. Measures of
MCA diameter (so that CBF can be calculated) but
also total grey matter volume enabled determination
of the impaired cerebral vasodilatory outcomes.
Second these data outline the concern that the sole

use of CVR may be misleading when used to study
cerebrovascular health due to compensatory central
hemodynamic responses.
This study provides the ﬁrst observations of MCA
cross-sectional area changes in young and older adults.
The dilation of about 8% in YA replicates earlier
results.13,14 Although we observed a diﬀerence when
comparing percent change in the MCA between
groups, this diﬀerence potentially was aﬀected by the
non-signiﬁcant smaller baseline diameter in the YA
group because the change in MCA CSA, as well as
absolute values, were not diﬀerent between groups.
The somewhat greater baseline arterial CSA in the
OA group may reﬂect a generalized eﬀect of age that
are reported in the carotid artery, likely as a result of
the change in the elastic properties of the artery with
aging.22 Additionally, in two of the OA participants, a
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Figure 4. Cerebrovascular conductance (CVCGM; a) at baseline and hypercapnia and the absolute (b) and percent change (c) from
baseline to hypercapnia in young adults (YA) and older adults (OA). *P < 0.05 versus baseline; yP < 0.05 versus YA.

decrease in CSA was noted in response to hypercapnia.
One of these participants was on the anti-epileptic
medication. It is unclear whether this would have had
an eﬀect on our results but there is some evidence that
these medications aﬀect the peripheral vasculature;
either directly or via an indirect inﬂuence by modiﬁcation of risk factors.23 For example, anti-epileptic medications may increase cholesterol levels, thus causing
atherogenesis and increased IMT.24 In this study,
IMT was not diﬀerent than the group average for the
participant on clobazam (left IMT was 0.64 mm and
right was 0.81). No apparent reason can be found to
explain the second participant’s constrictor pattern.
Furthermore, another of the OA participants was on
warfarin. Long-term use of vitamin K-antagonists has
been associated with calciﬁcation of the coronary
arteries.25 It is unclear if a similar eﬀect occurs in the
cerebral vessels. However, the change in MCA CSA
with hypercapnia in this participant (0.57 mm) was
similar to the group average, as was the average IMT

(0.68 mm for both right and left common carotid
arteries). Therefore, data for this participant were
retained in the analysis. An additional important
aspect of these observations is the inter-individual variability of the MCA responses to hypercapnia which was
greater in the YA than OA. In fact, the YA group is
characterized by considerable variability in this
response, an outcome that we have observed previously
in two separate groups of similarly aged
individuals.13,14
Determining the mechanism(s) involved in the
impaired CVC outcome in the OA group was beyond
the scope of this study but may include arterial stiﬀening or impaired endothelial function as it pertains to
hypercapnic or shear stress stimuli. Extracellular pH of
the cerebrovasculature is the main mediator of the
hypercapnia-induced increase in CBF26 via an eﬀect
on potassium channels27 and it is unclear how aging
may aﬀect these channels. In addition, nitric oxide
and prostaglandins may also play a role in this
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Figure 5. Absolute (a) and relative (b) cerebrovascular reactivity (CVRGM) at baseline and hypercapnia in young adults (YA) and
older adults (OA) and the error in calculating CVRGM when CBFVGM was used instead of CBFGM for YA and OA (c). *P < 0.05 versus
CBFVGM; yP < 0.05 versus YA.

response.4,28 Unfortunately, diﬃculties arise in studying endothelial function in the intact, conscious human
brain. Nonetheless, pharmacological approaches indicate an impairment of the hypercapnic increase in
CBFV following nitric oxide synthase blockade as measured with TCD in humans29 and CBF with the 133Xe
clearance method in rats.30 Additionally, administration of a nitric oxide donor to patients with endothelial
dysfunction restored CVR, measured with TCD, to
levels
of
healthy
age-matched
controls.28
However, the ﬁndings are equivocal with other studies
showing no eﬀect of nitric oxide inhibition on the
response to hypercapnia in humans.31,32 Perhaps blockade of one pathway results in upregulation of another
(for example, the prostaglandin pathway) since it is not
the nitric oxide pathway alone that is responsible for
the hyperemic response to hypercapnia. Additionally,
when indomethacin is administered to block the

prostaglandin pathway in humans, a diﬀerence in YA
and OA in baseline TCD CBFV and CVR is abolished,
a ﬁnding that suggests impairment of the prostaglandin-mediated response to hypercapnia.4
While measures of cerebral endothelial function
could not be obtained from the current study, measures
of greater carotid intima-media thickness, diminished
brachial artery ﬂow-mediated dilation, and heightened
levels of circulating lipids, are consistent with an overall
reduction in endothelial health in the OA group.33–35
These data conﬁrm the ﬁndings of Barnes et al. based
on TCD CBFV measures.4 Additionally, Barnes et al.4
found no diﬀerences in CVC between young and older
adults when indomethacin was administered. These
ﬁndings suggest that with age, one pathway that may
be altered is endothelial cyclooxygenase-mediated dilation. Our results add to these ﬁndings because they
conﬁrm that changes in CVC, calculated based on
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CBF rather than CBFV, are diminished in OA, and
that these changes occur in the presence of peripheral
vascular endothelial impairment.
A second major outcome of this study was the observation that while healthy aging may reduce the change
in CVC (that is, the dilation response), this outcome
cannot be concluded from standard measures of
CVR. Previously, reports on the impact of age on
CVR were based primarily on mean CBFV through
the MCA,4,6,10,11 without taking into account the
eﬀect of MCA CSA. In agreement with previous studies, CVR calculated using CBFV in the current study
was the same between groups.10,11
The discussion above outlines the problem that
measures of CVRGM and CVCGM support opposing
conclusions in the context of studying human cerebrovascular health. These ﬁndings lead to the question of
whether CVR or CVC is a more appropriate metric for
examining the dilatory capacity of the cerebrovasculature. CVR does not measure vasodilation per se, but
only the ﬂow response relative to the magnitude of the
stimulus. In turn, changes in ﬂow can be induced by
either a change in downstream conductance and/or by a
change in the perfusion pressure gradient. The cerebrovascular pressure gradient, comprised of mean arterial
pressure, intra-cranial pressure, and venous pressure,
remains diﬃcult to measure in humans. However, the
systemic blood pressure determines to a large extent the
intracranial pressure gradient. Nonetheless, rarely is
blood pressure measured or reported in CVR measures
despite evidence that hypercapnia elevates blood pressure.10,11,36,37 The current study indicated that the pressor response to hypercapnia is greater in OA compared
to YA. By accounting for changes in mean arterial pressure, the current calculation of CVCGM exposed the
reduced dilatory response in the OA. Therefore, the
aging process appears to include compensatory central
hemodynamic responses to preserve CBF adjustments
during hypercapnia despite limited cerebral vasodilation. This conclusion is preceded by evidence that
MAP has an independent eﬀect on mean ﬂow velocity
during hypercapnia. Speciﬁcally, above a threshold
PETCO2, increases in mean arterial pressure with
PETCO2 have a linear relationship with CBFV.36 As
well, Claassen et al. found that the magnitude of
increase in an index of CVC (CBFV/MAP) during a
rebreathing challenge was greater than the magnitude
of change in CBFV which suggests that MAP has a
direct eﬀect on CBFV.37 Clearly, there is an integrated
response to hypercapnia that contributes to cerebral
blood ﬂow and these factors should be considered
when examining CVR.
We examined the relationship between grey matter
volume and cerebrovascular indices based on the idea
that there is a linkage between total CBF and tissue
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atrophy. Previous studies have reported decreased
CBFV in OA compared to YA,4–6 but did not consider
the volume of brain tissue perfused. Once normalized to
grey matter volume, group-based diﬀerences in baseline
CBFVGM, CBFGM, or CVRGM were not evident in the
current study. However, a diﬀerence in CVC between
groups was present during hypercapnia even when normalized to grey matter volume. This normalization
approach did not take into account the limited perfusion region of the MCA which could not be quantiﬁed
in the current study. A further limitation of the current
approach is that total blood ﬂow may not reﬂect ﬂow
patterns at the microvascular region. For example,
Chen et al. examined voxel-wise measures of cortical
blood ﬂow using MRI perfusion methods (arterial
spin labelling), as well as cortical thickness, and
reported that, on the voxel-wise scale, reduction in
CBF with aging can be dissociated from the concurrent
process of cortical atrophy.17 Therefore, our results
suggest that while an overall relationship exists between
CBF and grey matter volumes, the pattern may become
dissociated at the voxel scale.
In conclusion, this study was the ﬁrst to show that
patterns of MCA dilation, and central arterial pressor
responses, form important determinants of the cerebrovascular response to hypercapnia. However, in this
study, the increase in MAP to hypercapnia makes it
diﬃcult to determine whether the results reﬂect an
age-related diﬀerence in reactivity to CO2 or to pressure-dependent vascular eﬀects. Overall, the vascular
bed supplied by the MCA, but not the MCA itself,
displayed impaired dilation to hypercapnia in healthy
older adults. Further, our studies support the idea that
measures of CVC, normalized to brain volume, provide
a more appropriate estimate of the dilatory capacity of
the cerebrovasculature than a traditional estimate of
CVR. In this regard, the impaired cerebrovascular dilatory response may be an important marker of cerebrovascular risk in healthy aging.
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